VEYVONDI is a prescription medication specifically designed for the treatment of adults diagnosed with von Willebrand disease (VWD), which is the most common hereditary bleeding disorder. It is used in situations where surgery or invasive procedures are planned, providing control over bleeding by mimicking the action of von Willebrand factor (VWF), a protein in the blood that is essential for normal blood clotting. VEYVONDI works by temporarily increasing the levels of VWF in the body, thereby helping to manage bleeding episodes. It is administered intravenously and is intended for use under the guidance of healthcare professionals experienced in the treatment of bleeding disorders. VEYVONDI's effectiveness and safety profile have made it a valuable option in the management of VWD, offering patients the possibility of a more normal life with reduced risk of bleeding complications.